Pregnancy Interaction

• Mebeverine: Limited information is available; although animal studies have not demonstrated adverse effects, its use during pregnancy should be guided by a healthcare professional.
• Chlordiazepoxide: A member of the benzodiazepine class; it crosses the placenta and may result in fetal damage or withdrawal symptoms if administered late in pregnancy.
• Therefore, Mebizid C should be administered during pregnancy solely when the anticipated benefit exceeds the potential risk and exclusively under the supervision of a healthcare professional.
• It is not advised during breastfeeding, as chlordiazepoxide may be excreted into breast milk and could induce sedation in neonates.

FAQs for Medicine?

1. What is the purpose of the Mebizid C Tablet?

It is utilized to alleviate abdominal pain, bloating, cramping, and discomfort related to irritable bowel syndrome (IBS), spastic colon, and motility disorders of the intestine, particularly when anxiety exacerbates the symptoms.

2. Is it permissible to consume it on a daily basis?

Yes, in accordance with your physician’s prescription. Typically, it is administered as one tablet two to three times daily prior to meals, depending on the severity of symptoms.

3. Does it provide a permanent remedy for IBS?

No, Mebizid C assists in managing and alleviating the symptoms of IBS but does not eradicate the underlying condition. Dietary regulation and stress mitigation continue to be crucial.

4. Is it considered safe to use during pregnancy or while breastfeeding?

Refrain from using unless explicitly instructed. Due to its content of chlordiazepoxide, it may have an impact on the infant during pregnancy or breastfeeding.

5. Is it capable of inducing drowsiness?

Yes, moderate drowsiness or sedation may result from the chlordiazepoxide component. Refrain from driving or operating heavy apparatus until you are aware of how it impacts you.

Expert advice

• Take Mebizid C consistently as directed to achieve optimal control of abdominal cramping and bowel spasms.
• Refrain from consuming alcohol or other central nervous system depressants, as they may augment the sedative effects of chlordiazepoxide.
• Maintain proper hydration and consume fiber-rich meals; dietary modifications support the treatment.
• Do not discontinue the medication abruptly without consulting your physician—chlordiazepoxide may induce withdrawal symptoms if unexpectedly stopped following extended use.
• This medication is not advised for prolonged uninterrupted use unless subject to careful medical oversight.
• Please inform your physician if you have any liver, kidney, or respiratory issues.

Side Effects

• Drowsiness, lethargy, or dizziness
• Xerostomia or moderate nausea
• Constipation or modest abdominal discomfort
• Allergic response (rash, pruritus—rare)
• In uncommon instances, confusion or dependence may occur with prolonged use due to the presence of benzodiazepines.
• If you encounter severe vertigo, difficulty breathing, or an allergic reaction, discontinue the medication and seek immediate medical attention from your healthcare provider.

How it works

• Mebeverine Hydrochloride: A musculotropic antispasmodic agent that relaxes the smooth muscles of the gastrointestinal tract without impairing normal bowel motility. It assists in alleviating cramping, abdominal discomfort, and spasms associated with conditions such as IBS.
• Chlordiazepoxide: A benzodiazepine derivative exhibiting anxiolytic and moderate sedative effects. It influences the central nervous system to alleviate anxiety, which frequently exacerbates IBS symptoms.
• Together, they function synergistically—mebeverine alleviates intestinal spasms, while chlordiazepoxide diminishes stress-induced gastrointestinal disturbances.

Medicine Interaction

• CNS depressants (alcohol, sedatives, opioids): May increase sedation and the risk of respiratory depression.
• Antihistamines, antipsychotics, and antidepressants: May enhance sedative effects.
• Antacids or proton-pump inhibitors: May marginally affect absorption, although not in a manner that is clinically significant.
• CYP-metabolized drugs: Chlordiazepoxide may interact with specific hepatic enzyme inducers or inhibitors.
• Always notify your healthcare provider of any other medications or supplements you are currently taking prior to initiating Mebizid C.

How to use

• Dosage: As prescribed by your physician, typically one tablet administered two to three times daily prior to meals.
• Swallow the entire tablet with water; do not pulverize or chew.
• Administer at the same times daily for consistent symptom management.
• If a dose is omitted, it should be taken at the earliest opportunity upon recall. If it is nearly time for the next scheduled dose, omit the delayed dose—do not administer a double dose.
• Refrain from consuming alcohol while taking this medication.

Uses/Indications

• Irritable Bowel Syndrome (IBS)—characterized by abdominal discomfort and alternating episodes of constipation and diarrhea
• Spastic colon and inflammatory colitis
• Gastrointestinal spasms resulting from tension or anxiety
• Functional gastrointestinal disorders (non-ulcer dyspepsia, flatulence)
• Psychosomatic gastrointestinal conditions in which anxiety induces intestinal distress